John M. Davis, MD

Article

Choice of Maintenance Medication for Schizophrenia

November 1, 2003

Original Research

Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial

October 15, 2003

Original Research

The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials

October 1, 2001

Original Research

The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials

December 15, 1997